Consolidated Statements of Income | Financial Information | Investor Relations

Consolidated Statements of Income Full Year （64KB）
P/L Trend

（Millions of Yen）

	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	954,714	1,052,943	1,205,846	1,567,421	1,672,377	1,814,663	1,917,478	2,036,366
Cost of sales	408,912	424,463	432,446	497,021	511,131	520,449	529,522	530,095
Selling, general and administrative expenses	406,581	468,032	591,964	902,586	1,007,606	1,110,979	1,115,977	1,220,903
Other income and expenses	1,308	-8,171	-19,310	21,690	160,894	24,957	43,055	55,954
Adjusted EBITDA~{1}	n.a.	n.a.	294,837	331,486	332,610	414,917	470,831	496,681
Adjusted EBITDA margin	n.a.	n.a.	24.5%	21.1%	19.9%	22.9%	24.6%	24.4%
Operating income	140,528	152,276	162,125	189,503	314,533	208,191	315,033	341,322
Other non-operating income and expenses	383	7,942	-91	15,174	-40,586	-10,078	-30,473	-39,594
Equity in earnings (Losses) of associates	-17,541	-24,542	-19,418	-46,135	-38,728	-16,491	-9,677	-7,496
Income before income taxes	123,370	135,676	142,615	158,542	235,219	181,621	274,882	294,231
Net Income	77,828	88,020	89,120	91,631	189,163	139,073	202,403	283,090
Net income attributable to owners of the parent	78,677	81,675	70,145	77,316	178,868	113,199	153,465	193,692
Adjusted EPS (JPY)~{2}	n.a.	18.66	18.27	10.77	5.37	22.31	24.91	28.73

Notes

1. Adjusted EBITDA: Operating income + Depreciation & amortization ± EBITDA adjustment items
Depreciation & amortization: Depreciation, depreciation of right-of-use assets, certain rents
EBITDA adjustment items: Gains/losses on non-recurring and non-cash transactions within operating revenue and expenses (loss on retirement of fixed assets, impairment losses, stock compensation expenses, gain on remeasurement relating to business combinations, other transactions with undetermined cash outflows (one-time provisions, etc.), etc.) Also, gains/losses on sales of shares held by certain funds. The definitions have been changed from FY2022-Q3.
Added certain rents to depreciation and amortization, and gains/losses on sales of shares held by certain funds to EBITDA adjustment items. Said income and expense for FY2022-Q1 and Q2 are lumped together and adjusted in FY2022-Q3.

2. Adjusted EPS: Adjusted net income / Average number of stocks outstanding (common stock) (quarterly cumulative)
Adjusted net income: Net income attributable to owners of the parent ± EPS adjustment items (*3) ± tax equivalent on some EPS adjustment items
EPS adjustment items: ± EBITDA adjustment items + amortization of identifiable intangible assets arising from business combinations ± non-recurring gains/losses in non-operating income/expenses
(Note) Starting from the fiscal year ended March 31, 2025, "amortization of identifiable intangible assets arising from business combinations" and "non-recurring gains/losses in non-operating income/expenses" are added to the formula for adjusted net income. Tax equivalent is also adjusted considering such adjustment items.